Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix’s Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection
Expands Ongoing Research Collaboration Between Tonix and MGH Studying TNX-1500 in Heart Transplantation
TNX-1500 May Hold Potential in Treating Autoimmune Diseases Including Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis
www.tonixpharma.com/news-events/...achusetts-general-hospital
TNX-1500 gegen Systemischer Lupus erythematodes (SLE) wäre ein Meilenstein. Ich hatte damals Human Genome Sciences zu 0,80€ gekauft und dann wurden sie von GSK geschluckt und BENLYSTA bekam die EU Zulassung.